# V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer

> **NCT03916757** · PHASE2 · UNKNOWN · sponsor: **Immunitor LLC** · enrollment: 20 (estimated)

## Conditions studied

- Glioblastoma Multiforme
- Glioma of Brain

## Interventions

- **BIOLOGICAL:** V-Boost

## Key facts

- **NCT ID:** NCT03916757
- **Lead sponsor:** Immunitor LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-16
- **Primary completion:** 2020-04-15
- **Final completion:** 2020-06-15
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2019-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03916757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03916757, "V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03916757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*